ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,408, issued on Jan. 27, was assigned to Merck Patent GmbH (Darmstadt, Germany).
"Treatment regimen for the treatment of autoimmune disorders" was invented by Ursula Boschert (Eysins, Switzerland) and Urs Wiedemann (Munich).
According to the abstract* released by the U.S. Patent & Trademark Office: "A novel treatment regimen is provided for the treatment of autoimmune disorders. Said novel treatment regimen provides for an efficacious treatment of autoimmune disorders with an advantageous safety profile and/or a high quality of life for the patient. Said novel treatment regimen provides for an advantageous benefit-risk ratio for patients endangered by the risk of infections."
The...